A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Description

This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.

Conditions

Hematologic Malignancies, Inherited Disorders of Metabolism, Inherited Abnormalities of Platelets, Histiocytic Disorders, Acute Myelogenous Leukemia (AML or ANLL), Acute Lymphoblastic Leukemia (ALL), Other Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplastic (MDS) / Myeloproliferative (MPN) Diseases, Other Leukemia, Hodgkin Lymphoma, Non-hodgkin Lymphoma, Multiple Myeloma/ Plasma Cell Disorder (PCD), Inherited Abnormalities of Erythrocyte Differentiation or Function, Disorders of the Immune System, Autoimmune Diseases, Severe Aplastic Anemia

Talk to us

Study Overview

On this page

Study Details

Study overview

This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients with Hematologic Malignancies and Other Indications

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Condition
Hematologic Malignancies
Intervention / Treatment

-

Contacts and Locations

Birmingham

University of Alabama at Birmingham, Birmingham, Alabama, United States, 35233

Gilbert

Banner MD Anderson Cancer Center, Gilbert, Arizona, United States, 85234

Phoenix

Phoenix Children's Hospital, Phoenix, Arizona, United States, 85016

Phoenix

Mayo Clinic Arizona (adults), Phoenix, Arizona, United States, 85054

Tucson

University of Arizona Medical Center - Tucson, Tucson, Arizona, United States, 85224

Duarte

City of Hope, Duarte, California, United States, 91010

Glendale

Children's Hospital of Los Angeles, Glendale, California, United States, 91204

La Jolla

University of California San Diego, La Jolla, California, United States, 92093

LaJolla

Scripps Green Hospital, LaJolla, California, United States, 92037

Loma Linda

Loma Linda University Cancer Center, Loma Linda, California, United States, 92350

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Disorders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment
  • * Signed informed consent (and signed assent, if applicable) obtained prior to study enrollment
  • * Pediatric and adult patients of any age
  • * Patients who are receiving only licensed CBUs
  • * Cord blood transplant recipients at international transplant centers
  • * Patients who are enrolled on another IND protocol to access the unlicensed CBU(s)
  • * Patients whose selected unlicensed CBU(s) will be more than minimally manipulated

Ages Eligible for Study

to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Center for International Blood and Marrow Transplant Research,

John Miller, MD, PhD, STUDY_CHAIR, NMDP/CIBMTR

Study Record Dates

2041-10